A detailed history of Mariner, LLC transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Mariner, LLC holds 14,196 shares of TSVT stock, worth $42,446. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,196
Previous 14,396 1.39%
Holding current value
$42,446
Previous $55,000 21.82%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$3.85 - $5.05 $770 - $1,010
-200 Reduced 1.39%
14,196 $67,000
Q2 2024

Aug 13, 2024

SELL
$3.6 - $5.79 $360 - $579
-100 Reduced 0.69%
14,396 $55,000
Q1 2024

May 15, 2024

SELL
$3.09 - $6.0 $862 - $1,674
-279 Reduced 1.89%
14,496 $77,000
Q4 2023

Feb 14, 2024

SELL
$1.57 - $4.58 $2,017 - $5,885
-1,285 Reduced 8.0%
14,775 $63,000
Q3 2023

Nov 13, 2023

BUY
$3.14 - $11.2 $9,102 - $32,468
2,899 Added 22.03%
16,060 $62,000
Q2 2023

Aug 11, 2023

SELL
$8.45 - $12.48 $44,852 - $66,243
-5,308 Reduced 28.74%
13,161 $133,000
Q1 2023

May 12, 2023

BUY
$9.21 - $14.98 $51,161 - $83,213
5,555 Added 43.02%
18,469 $188,000
Q4 2022

Feb 14, 2023

BUY
$8.57 - $17.0 $110,672 - $219,538
12,914 New
12,914 $121,000

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.